Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBINE-PMC
PACTR202610779490173Not yet recruiting
- Sponsor
- Institut de Recherche pour le Développement
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Open-label trial of sulfadoxine + pyrimethamine in malaria (2 arms), sponsored by Institut de Recherche pour le Développement. Primary endpoint: PMC coverage among children under 2 years. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202610779490173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202610779490173.